Innova Captab Limited - Asset Resilience Ratio

Latest as of March 2026: 2.25%

Innova Captab Limited (INNOVACAP) has an Asset Resilience Ratio of 2.25% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See INNOVACAP net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs412.85 Million

≈ $4.46 Million USD Cash + Short-term Investments

Total Assets

Rs18.37 Billion

≈ $198.71 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2026)

This chart shows how Innova Captab Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see INNOVACAP asset base.

Liquid Assets Composition Over Time

This chart breaks down Innova Captab Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read INNOVACAP total debt and obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs412.85 Million	2.25%
Total Liquid Assets	Rs412.85 Million	2.25%

Asset Resilience Insights

Limited Liquidity: Innova Captab Limited maintains only 2.25% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Innova Captab Limited Industry Peers by Asset Resilience Ratio

Compare Innova Captab Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	Drug Manufacturers - Specialty & Generic	-2.56%

Annual Asset Resilience Ratio for Innova Captab Limited (2019–2026)

The table below shows the annual Asset Resilience Ratio data for Innova Captab Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	2.25%	Rs412.85 Million ≈ $4.46 Million	Rs18.37 Billion ≈ $198.71 Million	-0.90pp
2025-03-31	3.15%	Rs497.62 Million ≈ $5.38 Million	Rs15.80 Billion ≈ $170.92 Million	-2.33pp
2024-03-31	5.48%	Rs723.64 Million ≈ $7.83 Million	Rs13.21 Billion ≈ $142.85 Million	+5.13pp
2023-03-31	0.34%	Rs35.00 Million ≈ $378.51K	Rs10.19 Billion ≈ $110.17 Million	+0.22pp
2022-03-31	0.13%	Rs7.23 Million ≈ $78.19K	Rs5.75 Billion ≈ $62.24 Million	-1.80pp
2021-03-31	1.92%	Rs70.99 Million ≈ $767.73K	Rs3.70 Billion ≈ $39.97 Million	+0.62pp
2020-03-31	1.30%	Rs49.45 Million ≈ $534.78K	Rs3.80 Billion ≈ $41.08 Million	+0.39pp
2019-03-31	0.92%	Rs30.12 Million ≈ $325.74K	Rs3.29 Billion ≈ $35.53 Million	--

pp = percentage points

About Innova Captab Limited

NSE:INNOVACAP India Drug Manufacturers - Specialty & Generic

Market Cap

$727.41 Million

Rs67.26 Billion INR

Market Cap Rank

#10490 Global

#525 in India

Share Price

Rs1175.40

Change (1 day)

+4.44%

52-Week Range

Rs644.75 - Rs1175.40

All Time High

Rs1240.00